The private sector is stepping up efforts to complement Government’s fight against cancer, with Stanbic Bank Zimbabwe doubling its annual contribution to the Cancer Association of Zimbabwe (CAZ) to US$50 000, to help patients access chemotherapy treatment.
The contribution, increased from US$25 000 in 2025, strengthens a partnership spanning more than a decade and supports efforts to ease the financial burden of cancer treatment on patients and their families.
Stanbic Bank head of brand and marketing, Tariro Memo said the bank’s continued support reflected its commitment to improving access to cancer care through corporate social investment initiatives.
“Today, Stanbic Bank Zimbabwe is therefore pleased to continue this journey through our contribution of US$50 000 towards chemotherapy drugs, which is double what we donated last year,” she said.
Memo said the partnership with CAZ went beyond financial assistance, helping patients and families navigate the challenges associated with cancer diagnosis and treatment.
She said the bank’s investment in health and sanitation was part of its broader commitment to supporting communities and delivering sustainable, measurable social impact.
“Our purpose is simple: Zimbabwe is our home, and we drive her growth. Health and sanitation are among the important areas of our community investment, and supporting cancer care remains part of that commitment,” she said.
Memo also commended CAZ for its work in cancer awareness, counselling, advocacy and support for patients and their families since its establishment in 1961.
She said the partnership was particularly important in extending cancer awareness and services beyond major urban centres, where rural communities continue to face challenges relating to awareness, early detection and access to treatment.
Cancer remains a major public health concern, making collaboration among Government, healthcare institutions, civil society and the private sector important in expanding access to services and improving patient outcomes.
CAZ General Manager, Junior Mavu said Stanbic Bank’s contribution would help provide essential chemotherapy treatment to patients who might otherwise struggle to afford it.
“We are especially grateful that your contribution has doubled from US$25 000 in 2025 to US$50 000 this year. This is a meaningful response to the growing cancer burden and the rising number of patients who need our help,” she said.
The contribution highlights the role of private-sector investment in complementing broader national efforts to strengthen healthcare delivery, improve access to treatment and support vulnerable patients.
